Increlex (Ipsen Biopharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Increlex drug offered from Ipsen Biopharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ipsen Biopharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | mecasermin |
| SUBSTANCE NAME: | MECASERMIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-01-03 |
| END MARKETING DATE: | 0000-00-00 |
Increlex HUMAN PRESCRIPTION DRUG Details:
| Item Description | Increlex from Ipsen Biopharmaceuticals, Inc. |
| LABELER NAME: | Ipsen Biopharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/4mL) |
| START MARKETING DATE: | 2006-01-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 15054-1040_0692f231-a29f-46e9-b1ba-85427e906d99 |
| PRODUCT NDC: | 15054-1040 |
| APPLICATION NUMBER: | NDA021839 |
Other MECASERMIN Pharmaceutical Manufacturers / Labelers:
